Scorecard › ORCL
ORCL analyst scorecard · Oracle Corporation
108 rating actions on ORCL in the last 12 months. Of 163 price targets that resolved, 60 were reached while they stood, 98 were replaced by the same firm first, and 5 fell short at their deadline. Ratings: 82% Buy-type, 18% Hold-type, 0% Sell-type. Consensus target $236, 71% above the last close.
Checked through 2026-10-29 · last close $138.21 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
36.8% 60 of 163
Replaced before the deadline
60.1%
Short at the deadline
3.1%
Ratings vs XLK
1 of 24
Buy / Hold / Sell, 12 mo
82 / 18 / 0%
Consensus target
$236 +70.7%
What the Holds say: 19 Hold-type ratings on ORCL in the last 12 months carried a median target +16% from the price on the day; 21% sat below it.
The 3 upgrades on ORCL came after an average -12.0% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Overweight | 2026-10-29 | $225 | 2 | 6 | 8 | 0 of 1 |
| Wedbush | Outperform | 2026-06-11 | $240 | 0 | 3 | 3 | — |
| Guggenheim | Buy | 2026-09-11 | $400 | 1 | 6 | 8 | 0 of 1 |
| UBS | Buy | 2026-09-11 | $250 | 1 | 11 | 12 | 0 of 1 |
| Scotiabank | Sector Outperform | 2026-09-09 | $215 | 2 | 6 | 8 | 0 of 1 |
| DA Davidson | Buy | 2026-09-11 | $225 | 4 | 2 | 6 | — |
| BMO Capital | Outperform | 2026-09-11 | $195 | 5 | 5 | 10 | 0 of 1 |
| Cantor Fitzgerald | Overweight | 2026-10-22 | $284 | 2 | 3 | 5 | 0 of 1 |
| Citigroup | Buy | 2026-06-04 | $330 | 1 | 7 | 8 | 0 of 1 |
| TD Cowen | Buy | 2026-10-29 | $240 | 1 | 7 | 8 | 0 of 1 |
| Barclays | Overweight | 2026-09-11 | $252 | 3 | 5 | 8 | 0 of 1 |
| Goldman Sachs | Buy | 2026-10-23 | $206 | 1 | 1 | 2 | — |
| CLSA | Hold | 2026-07-20 | $145 | 1 | 0 | 1 | — |
| Mizuho | Outperform | 2026-03-16 | $320 | 3 | 2 | 5 | 0 of 1 |
| KeyBanc | Overweight | 2025-12-11 | $300 | 1 | 2 | 3 | 0 of 1 |
| RBC Capital | Sector Perform | 2026-09-11 | $165 | 4 | 3 | 7 | — |
| Stephens & Co. | Equal-Weight | 2026-09-11 | $175 | 2 | 2 | 4 | — |
| Citizens | Market Outperform | 2026-10-02 | $285 | — | — | 0 | — |
| Bernstein | Outperform | 2026-06-11 | $325 | 1 | 2 | 3 | 0 of 1 |
| Bank of America | Buy | 2026-06-09 | $240 | 3 | 2 | 5 | 0 of 1 |
| JPMorgan | Overweight | 2026-03-11 | $210 | 3 | 3 | 6 | — |
| Stifel | Buy | 2026-09-11 | $200 | 2 | 3 | 5 | 0 of 1 |
| Morgan Stanley | Equal-Weight | 2026-09-04 | $210 | 2 | 2 | 4 | — |
| Oppenheimer | Outperform | 2026-10-29 | $275 | 2 | 0 | 2 | — |
| Jefferies | Buy | 2026-09-02 | $290 | 1 | 7 | 8 | 0 of 1 |
| Evercore ISI Group | Outperform | 2026-06-08 | $245 | 4 | 3 | 7 | 0 of 1 |
| Baird | Outperform | 2026-03-10 | $200 | 1 | 2 | 3 | 0 of 1 |
| Deutsche Bank | Buy | 2026-03-09 | $300 | 1 | 1 | 2 | 0 of 1 |
| Wells Fargo | Overweight | 2026-10-26 | $250 | — | — | 0 | — |
| Freedom Broker | Buy | 2026-09-14 | $205 | — | — | 0 | — |
| Argus Research | Buy | 2026-09-14 | $225 | — | — | 0 | — |
| BTIG | Buy | 2026-06-05 | $400 | — | — | 0 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor ORCL carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | TD Cowen | Buy | reiterated | $138.21 | $240 | running to 2027-10-29 | +0.3% |
| 2026-10-29 | Oppenheimer | Outperform | reiterated | $138.21 | $275 | running to 2027-10-29 | +0.3% |
| 2026-10-29 | Piper Sandler | Overweight | maintained | $138.21 | $225 | running to 2027-10-29 | +0.3% |
| 2026-10-26 | Wells Fargo | Overweight | maintained | $126.06 | $250 | running to 2027-10-26 | -8.1% |
| 2026-10-23 | Goldman Sachs | Buy | maintained | $126.16 | $206 | running to 2027-10-23 | -12.7% |
| 2026-10-22 | Cantor Fitzgerald | Overweight | reiterated | $125.54 | $284 | running to 2027-10-22 | -15.9% |
| 2026-10-02 | Citizens | Market Outperform | reiterated | $142.30 | $285 | running to 2027-10-02 | -2.4% |
| 2026-09-14 | Freedom Broker | Buy | maintained | $144.79 | $205 | running to 2027-09-14 | -3.8% |
| 2026-09-14 | Argus Research | Buy | reiterated | $144.79 | $225 | running to 2027-09-14 | -3.8% |
| 2026-09-11 | Stifel | Buy | maintained | $150.28 | $200 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | TD Cowen | Buy | reiterated | $150.28 | $240 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | UBS | Buy | maintained | $150.28 | $250 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | DA Davidson | Buy | maintained | $150.28 | $225 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | RBC Capital | Sector Perform | maintained | $150.28 | $165 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | Barclays | Overweight | maintained | $150.28 | $252 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | Guggenheim | Buy | reiterated | $150.28 | $400 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | BMO Capital | Outperform | maintained | $150.28 | $195 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | Stephens & Co. | Equal-Weight | reiterated | $150.28 | $175 | running to 2027-09-11 | -2.0% |
| 2026-09-11 | Cantor Fitzgerald | Overweight | reiterated | $150.28 | $284 | running to 2027-09-11 | -2.0% |
| 2026-09-09 | Scotiabank | Sector Outperform | maintained | $161.63 | $215 | running to 2027-09-09 | +7.0% |
| 2026-09-09 | Citizens | Market Outperform | reiterated | $161.63 | $285 | running to 2027-09-09 | +7.0% |
| 2026-09-08 | Guggenheim | Buy | reiterated | $162.52 | $400 | running to 2027-09-08 | +10.5% |
| 2026-09-04 | Morgan Stanley | Equal-Weight | maintained | $158.78 | $210 | running to 2028-03-04 | +10.0% |
| 2026-09-04 | RBC Capital | Sector Perform | reiterated | $158.78 | $190 | replaced 2026-09-11, new $165 | +10.0% |
| 2026-09-02 | Jefferies | Buy | maintained | $145.75 | $290 | running to 2027-09-02 | +2.8% |
| 2026-09-01 | TD Cowen | Buy | maintained | $141.32 | $240 | running to 2027-09-01 | +8.8% |
| 2026-08-06 | UBS | Buy | maintained | $143.47 | $245 | replaced 2026-09-11, new $250 | +1.3% |
| 2026-07-20 | CLSA | Hold | initiated | $121.38 | $145 | reached 2026-08-04 | -34.1% |
| 2026-06-11 | Bernstein | Outperform | maintained | $184.10 | $325 | running to 2027-06-11 | -1.5% |
| 2026-06-11 | RBC Capital | Sector Perform | reiterated | $184.10 | $190 | within 5% of price when set | -1.5% |
| 2026-06-11 | TD Cowen | Buy | reiterated | $184.10 | $300 | replaced 2026-09-01, new $240 | -1.5% |
| 2026-06-11 | Barclays | Overweight | maintained | $184.10 | $250 | replaced 2026-09-11, new $252 | -1.5% |
| 2026-06-11 | Cantor Fitzgerald | Overweight | reiterated | $184.10 | $284 | running to 2027-06-11 | -1.5% |
| 2026-06-11 | Wedbush | Outperform | maintained | $184.10 | $240 | running to 2027-06-11 | -1.5% |
| 2026-06-11 | Stephens & Co. | Equal-Weight | reiterated | $184.10 | $164 | reached 2026-06-24 | -1.5% |
| 2026-06-11 | Guggenheim | Buy | reiterated | $184.10 | $400 | running to 2027-06-11 | -1.5% |
| 2026-06-11 | DA Davidson | Buy | maintained | $184.10 | $225 | running to 2027-06-11 | -1.5% |
| 2026-06-11 | Scotiabank | Sector Outperform | maintained | $184.10 | $241 | replaced 2026-09-09, new $215 | -1.5% |
| 2026-06-11 | BMO Capital | Outperform | maintained | $184.10 | $220 | replaced 2026-09-11, new $195 | -1.5% |
| 2026-06-11 | Piper Sandler | Overweight | maintained | $184.10 | $225 | running to 2027-06-11 | -1.5% |
| 2026-06-09 | Bank of America | Buy | maintained | $205.81 | $240 | running to 2027-06-09 | +5.0% |
| 2026-06-08 | Evercore ISI Group | Outperform | maintained | $211.82 | $245 | running to 2027-06-08 | +8.1% |
| 2026-06-08 | Oppenheimer | Outperform | maintained | $211.82 | $275 | running to 2027-06-08 | +8.1% |
| 2026-06-08 | TD Cowen | Buy | maintained | $211.82 | $300 | replaced 2026-09-01, new $240 | +8.1% |
| 2026-06-05 | Cantor Fitzgerald | Overweight | maintained | $213.68 | $284 | running to 2027-06-05 | +10.1% |
| 2026-06-05 | RBC Capital | Sector Perform | maintained | $213.68 | $190 | reached 2026-06-11 | +10.1% |
| 2026-06-05 | BTIG | Buy | reiterated | $213.68 | $400 | running to 2027-06-05 | +10.1% |
| 2026-06-04 | Citigroup | Buy | maintained | $236.34 | $330 | running to 2027-06-04 | +27.5% |
| 2026-06-02 | UBS | Buy | maintained | $244.58 | $285 | replaced 2026-08-06, new $245 | +42.3% |
| 2026-06-02 | Scotiabank | Sector Outperform | maintained | $244.58 | $290 | replaced 2026-06-11, new $241 | +42.3% |
| 2026-05-13 | Wedbush | Outperform | maintained | $189.76 | $275 | replaced 2026-06-11, new $240 | +21.9% |
| 2026-05-12 | Oppenheimer | Outperform | maintained | $186.83 | $235 | reached 2026-06-01 | +35.3% |
| 2026-04-29 | Wedbush | Outperform | reiterated | $163.83 | $225 | replaced 2026-05-13, new $275 | +18.0% |
| 2026-04-24 | Wedbush | Outperform | initiated | $173.28 | $225 | replaced 2026-05-13, new $275 | +18.7% |
| 2026-04-23 | Morgan Stanley | Equal-Weight | maintained | $176.28 | $207 | reached 2026-05-29 | +19.8% |
| 2026-04-07 | Stephens & Co. | Equal-Weight | reiterated | $143.17 | $254 | replaced 2026-06-11, new $164 | -6.4% |
| 2026-03-16 | Mizuho | Outperform | maintained | $155.97 | $320 | running to 2027-03-16 | -2.6% |
| 2026-03-13 | Guggenheim | Buy | reiterated | $155.11 | $400 | running to 2027-03-13 | -1.3% |
| 2026-03-12 | Citigroup | Buy | maintained | $159.16 | $320 | replaced 2026-06-04, new $330 | -0.5% |
| 2026-03-11 | Stifel | Buy | maintained | $163.12 | $220 | reached 2026-05-29 | +4.2% |
| 2026-03-11 | Barclays | Overweight | maintained | $163.12 | $240 | reached 2026-06-01 | +4.2% |
| 2026-03-11 | BMO Capital | Outperform | maintained | $163.12 | $200 | reached 2026-05-28 | +4.2% |
| 2026-03-11 | TD Cowen | Buy | reiterated | $163.12 | $250 | replaced 2026-06-08, new $300 | +4.2% |
| 2026-03-11 | RBC Capital | Sector Perform | reiterated | $163.12 | $160 | within 5% of price when set | +4.2% |
| 2026-03-11 | JPMorgan | Neutral → Overweight | upgrade | $163.12 | $210 | reached 2026-05-29 | +4.2% |
| 2026-03-11 | DA Davidson | Buy | maintained | $163.12 | $200 | reached 2026-05-28 | +4.2% |
| 2026-03-11 | Cantor Fitzgerald | Overweight | reiterated | $163.12 | $229 | reached 2026-06-01 | +4.2% |
| 2026-03-11 | Piper Sandler | Overweight | maintained | $163.12 | $210 | reached 2026-05-29 | +4.2% |
| 2026-03-10 | Baird | Outperform | maintained | $149.40 | $200 | reached 2026-05-28 | +4.6% |
| 2026-03-09 | Deutsche Bank | Buy | maintained | $151.56 | $300 | running to 2027-03-09 | +6.1% |
| 2026-03-09 | Scotiabank | Sector Outperform | maintained | $151.56 | $215 | reached 2026-05-29 | +6.1% |
| 2026-03-09 | Barclays | Overweight | maintained | $151.56 | $230 | replaced 2026-03-11, new $240 | +6.1% |
| 2026-03-06 | Jefferies | Buy | maintained | $152.96 | $320 | replaced 2026-09-02, new $290 | +4.3% |
| 2026-03-06 | TD Cowen | Buy | maintained | $152.96 | $250 | replaced 2026-06-08, new $300 | +4.3% |
| 2026-03-05 | Evercore ISI Group | Outperform | maintained | $154.79 | $220 | reached 2026-05-29 | +0.1% |
| 2026-03-04 | Citigroup | Buy | maintained | $152.37 | $310 | replaced 2026-03-12, new $320 | -4.8% |
| 2026-03-04 | RBC Capital | Sector Perform | maintained | $152.37 | $160 | reached 2026-03-11 | -4.8% |
| 2026-02-25 | Oppenheimer | Perform → Outperform | upgrade | $147.89 | $185 | reached 2026-04-22 | -18.9% |
| 2026-02-09 | DA Davidson | Neutral → Buy | upgrade | $156.59 | $180 | replaced 2026-03-11, new $200 | -21.1% |
| 2026-02-05 | Citizens | Market Outperform | maintained | $136.48 | $285 | running to 2027-02-05 | -29.6% |
| 2026-02-03 | Scotiabank | Sector Outperform | maintained | $154.67 | $220 | replaced 2026-03-09, new $215 | -21.0% |
| 2026-02-03 | Piper Sandler | Overweight | maintained | $154.67 | $240 | replaced 2026-03-11, new $210 | -21.0% |
| 2026-02-02 | UBS | Buy | maintained | $160.06 | $250 | replaced 2026-06-02, new $285 | -18.2% |
| 2026-01-23 | Morgan Stanley | Equal-Weight | maintained | $177.16 | $213 | replaced 2026-04-23, new $207 | -10.3% |
| 2026-01-05 | UBS | Buy | maintained | $192.59 | $280 | replaced 2026-02-02, new $250 | -11.5% |
| 2026-01-05 | RBC Capital | Sector Perform | maintained | $192.59 | $195 | within 5% of price when set | -11.5% |
| 2026-01-05 | Jefferies | Buy | maintained | $192.59 | $400 | replaced 2026-03-06, new $320 | -11.5% |
| 2025-12-12 | Goldman Sachs | Neutral | maintained | $189.97 | $220 | reached 2026-05-29 | -16.3% |
| 2025-12-11 | UBS | Buy | maintained | $198.85 | $325 | replaced 2026-01-05, new $280 | -15.8% |
| 2025-12-11 | Citigroup | Buy | maintained | $198.85 | $370 | replaced 2026-03-04, new $310 | -15.8% |
| 2025-12-11 | DA Davidson | Neutral | maintained | $198.85 | $180 | reached 2025-12-17 | -15.8% |
| 2025-12-11 | JPMorgan | Neutral | maintained | $198.85 | $230 | replaced 2026-03-11, new $210 | -15.8% |
| 2025-12-11 | Scotiabank | Sector Outperform | maintained | $198.85 | $260 | replaced 2026-02-03, new $220 | -15.8% |
| 2025-12-11 | TD Cowen | Buy | maintained | $198.85 | $350 | replaced 2026-03-06, new $250 | -15.8% |
| 2025-12-11 | RBC Capital | Sector Perform | maintained | $198.85 | $250 | replaced 2026-01-05, new $195 | -15.8% |
| 2025-12-11 | Guggenheim | Buy | reiterated | $198.85 | $400 | running to 2026-12-11 | -15.8% |
| 2025-12-11 | Cantor Fitzgerald | Overweight | maintained | $198.85 | $320 | replaced 2026-03-11, new $229 | -15.8% |
| 2025-12-11 | KeyBanc | Overweight | maintained | $198.85 | $300 | running to 2026-12-11 | -15.8% |
| 2025-12-11 | Stifel | Buy | maintained | $198.85 | $275 | replaced 2026-03-11, new $220 | -15.8% |
| 2025-12-11 | Bernstein | Outperform | maintained | $198.85 | $339 | replaced 2026-06-11, new $325 | -15.8% |
| 2025-12-11 | BMO Capital | Outperform | maintained | $198.85 | $270 | replaced 2026-03-11, new $200 | -15.8% |
| 2025-12-11 | Bank of America | Buy | maintained | $198.85 | $300 | replaced 2026-06-09, new $240 | -15.8% |
| 2025-12-11 | Piper Sandler | Overweight | maintained | $198.85 | $290 | replaced 2026-02-03, new $240 | -15.8% |
| 2025-12-09 | Barclays | Overweight | maintained | $221.53 | $330 | replaced 2026-03-09, new $230 | -7.4% |
| 2025-12-04 | Citigroup | Buy | maintained | $214.33 | $375 | replaced 2025-12-11, new $370 | -13.6% |
| 2025-11-26 | Deutsche Bank | Buy | reiterated | $204.96 | $375 | replaced 2026-03-09, new $300 | — |
| 2025-11-25 | DA Davidson | Neutral | maintained | $197.03 | $200 | within 5% of price when set | — |
| 2025-11-18 | Baird | Outperform | maintained | $220.49 | $315 | replaced 2026-03-10, new $200 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.